Clinical Trial Update: Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder [NA]

View source ↗

Summary

This clinical trial compares toludesvenlafaxine hydrochloride sustained-release tablets against desvenlafaxine succinate sustained-release tablets for improving…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine succinate sustained-release tablets (desvenlafaxine succinate)
• Toludesvenlafaxine hydrochloride sustained-release tablets (toludesvenlafaxine hydrochloride)

Snippet

Sponsor: Jiangsu Province Nanjing Brain Hospital | Conditions: Anhedonia | NA | Status: RECRUITING